|Bid||0.0000 x 3000|
|Ask||0.0000 x 1800|
|Day's Range||2.3900 - 2.5300|
|52 Week Range||1.3500 - 13.4900|
|Beta (5Y Monthly)||1.87|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
DBV said it expects to receive the first set of questions from the EMA regarding marketing approval about 120 days post-validation.
Montrouge, France, July 7, 2020 DBV Technologies Announces Publication of PEOPLE Phase III Open-Label Extension Study Evaluating Viaskin Peanut in The Journal of Allergy and.
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of March 31st, a week after the market trough. Now, we are […]